STAGE III HEPATOCELLULAR CARCINOMA AJCC V7
Clinical trials for STAGE III HEPATOCELLULAR CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III HEPATOCELLULAR CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III HEPATOCELLULAR CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo takes on tough cancers: early trial hopes for better control
Disease control OngoingThis early-phase trial is testing a combination of two drugs—guadecitabine and durvalumab—in people with advanced liver, pancreatic, bile duct, or gallbladder cancers that have spread. Guadecitabine aims to block cancer cell growth, while durvalumab helps the immune system attack…
Matched conditions: STAGE III HEPATOCELLULAR CARCINOMA AJCC V7
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 22, 2026 11:55 UTC
-
Proton beam vs X-Rays: which radiation is better for liver cancer?
Disease control OngoingThis study compares two radiation therapies—proton therapy and standard photon (X-ray) therapy—for people with liver cancer that cannot be removed by surgery or has come back. The goal is to see if proton therapy, which stops after hitting the tumor, causes less harm to healthy o…
Matched conditions: STAGE III HEPATOCELLULAR CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC